Cellosaurus cell line 131.2F8.5.9 (CVCL

Cross-references
Cell line name	131.2F8.5.9
Synonyms	5.9; CHIR-5.9
Accession	CVCL_J991
Resource Identification Initiative	To cite this cell line use: 131.2F8.5.9 (RRID:CVCL_J991)
Comments	Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5542. Registration: Chiron Master Culture Collection; CMCC 12047 (CMCC #12047). Monoclonal antibody isotype: IgG1, kappa. Monoclonal antibody target: UniProtKB; P25942; Human CD40.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_2199 (Sp2/0-Ag14)
Category	Hybridoma
Publications	Patent=US20070098718 Long L., Luqman M., Yabannavar A., Zaror I. Methods of therapy for B cell-related cancers. Patent number US20070098718, 03-May-2007 Patent=US20070218060 Long L., Luqman M., Yabannavar A., Zaror I. Use of antagonist anti-CD40 monoclonal antibodies for treatment of multiple myeloma. Patent number US20070218060, 20-Sep-2007 Patent=US8333970 Aukerman S.L., Jallal B., Luqman M. Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease. Patent number US8333970, 18-Dec-2012
Cell line collections (Providers)	ATCC; PTA-5542
Encyclopedic resources	Wikidata; Q54581470
Entry history
Entry creation	11-Feb-2013
Last entry update	21-Mar-2023
Version number	8